Nuformix PLC – London-based pharmaceutical development company focused on fibrosis and oncology via drug repurposing – Hires Tim Metcalfe to be non-executive chair, starting September 1, Tuesday next week. Metcalfe is a corporate financier who among other City roles was joint CEO of Zeus Capital Ltd. At Nuformix, he replaces Julian Gilbert, who is stepping down for “personal reasons”. Gilbert has been on the board since 2020 and chair since 2022.
Current stock price: 0.17 pence, up 1.1% on Tuesday afternoon in London
12-month change: up from 0.070p
Copyright 2026 Alliance News Ltd. All Rights Reserved.
Source link
Author
- Ytv Market News
- Share-market news writer and analyst with deep experience covering equities, commodities, forex, and cryptocurrencies for readers in the USA, UK, Canada, and Australia. Ytv Market News delivers timely market updates, practical trading insights, and clear explanations of macro and company-level catalysts that move prices. Combines on-the-ground financial reporting with technical analysis, using concise charts and actionable ideas to help investors and traders make smarter decisions.
Latest entries
Company Press ReleasesAugust 25, 2026Leqembi Iqlik® for initiation treatment launched in the US
Company NewsAugust 25, 2026Die Northrop-Grumman-Aktie nähert sich 80-Milliarden-Marke bei stabiler Nachfrage
Stock Market VideosAugust 25, 2026US Debt Costs Climb; Farage Wins UK Special Election | Daybreak Europe 8/14/2026- UkAugust 25, 2026Lunchtime market roundup: Stocks up ahead of US ADP, home sales data
